The advertisement provides updates on guidelines for patients with chronic kidney disease (CKD) and highlights important safety information regarding SGLT2 inhibitors.
Creative Information
| CID: | cb894c8c-ee9d-430b-92b8-d92462ca72e9 |
| CRID: | 82_6919-875716 |
| Domain: | farxiga-hcp.com |
| Seat: | PP |
| Size: | 300x50 |
| Bid: | $4.92 |
| Timestamp: | 11/7/2025, 2:53:46 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 6:10:08 PM | 5.56s | |
| adomain_analysis | success | 11/7/2025, 8:28:34 PM | 4.26s | |
| adomain_capture | success | 11/7/2025, 8:28:21 PM | 0.10s | |
| ad_render | success | 11/7/2025, 6:10:02 PM | 27.52s | |
| brand_mapping | success | 11/7/2025, 2:53:47 PM | 0.14s | |
Analysis Results
Ad Format: banner
Brands: Farxiga
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x50 | ||||||||||||||||||||||
| Data Transferred: | 1746.13 KB | ||||||||||||||||||||||
| Render Time: | 11.51 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1811.00 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

